{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:30:31Z","timestamp":1789889431752,"version":"4.0.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US NIDA\/NIH","award":["DA07182"],"award-info":[{"award-number":["DA07182"]}]},{"name":"New Zealand Institute of Environmental Science and Research, Ltd."},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T22:06:39Z","timestamp":1435010799000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Low levels of astroglial markers in Parkinson\u2019s disease: relationship to \u03b1-synuclein accumulation"],"prefix":"10.1016","volume":"82","author":[{"given":"Junchao","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Cyn","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Guttman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh","family":"Hornykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.06.010_bb0005","first-page":"584","article-title":"Striato-nigral degeneration","volume":"23","author":"Adams","year":"1964","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.870130205","article-title":"Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease","volume":"13","author":"Banati","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0020","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2015.06.010_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.06.010_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2047-9158-2-20","article-title":"Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts","volume":"2","author":"Braidy","year":"2013","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.nbd.2015.06.010_bb0040","article-title":"Glia and alpha-synuclein in neurodegeneration: A complex interaction","author":"Bruck","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnagi.2014.00258","article-title":"Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?","volume":"6","author":"Charron","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0050","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.06.010_bb0055","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","article-title":"Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice","volume":"25","author":"Choi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","article-title":"Astrogliosis as a therapeutic target for neurodegenerative diseases","volume":"565","author":"Colangelo","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.06.010_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson's disease","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.06.010_bb0070","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/WNL.46.5.1262","article-title":"Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?","volume":"46","author":"Damier","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.06.010_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-196801000-00001","article-title":"Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue","volume":"27","author":"Earle","year":"1968","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0080","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menches und ihr verhalten bei erkrankungen des extrapyramiden systems","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.nbd.2015.06.010_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","article-title":"GFAP and astrogliosis","volume":"4","author":"Eng","year":"1994","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2015.06.010_bb0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00401-011-0833-z","article-title":"Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts","volume":"121","author":"Fellner","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0100","first-page":"266","article-title":"Pathology of parkinsonism. A preliminary report of 24 cases","volume":"24","author":"Forno","year":"1966","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.nbd.2015.06.010_bb0105","series-title":"Parkinson's disease","article-title":"Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies","author":"Forno","year":"1990"},{"key":"10.1016\/j.nbd.2015.06.010_bb0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","article-title":"Astrocytes and Parkinson's disease","volume":"94","author":"Forno","year":"1992","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2015.06.010_bb0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0120","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.06.010_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jnnp.16.4.213","article-title":"The brain-stem lesions in Parkinsonism","volume":"16","author":"Greenfield","year":"1953","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2015.06.010_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","article-title":"A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death","volume":"31","author":"Greffard","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.06.010_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice","volume":"3","author":"Gu","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.nbd.2015.06.010_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson's disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0145","first-page":"387","article-title":"Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus","volume":"48","author":"Hassler","year":"1938","journal-title":"J. Psychol. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0150","first-page":"822","article-title":"Extrapyramidal-motorische syndrome und erkrankungen","volume":"vol. V, part III","author":"Hassler","year":"1953"},{"key":"10.1016\/j.nbd.2015.06.010_bb0155","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.06.010_bb0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2015.06.010_bb0165","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","article-title":"Neuroinflammatory processes in Parkinson's disease","volume":"11","author":"Hirsch","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2990.2001.00345.x","article-title":"Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease","volume":"27","author":"Hishikawa","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.23795","article-title":"Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts","volume":"27","author":"Jellinger","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00688335","article-title":"A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis","volume":"74","author":"Kamo","year":"1987","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0185","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2015.06.010_bb0190","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1096\/fj.06-6183com","article-title":"Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells","volume":"20","author":"Klegeris","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.06.010_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1353-8020(99)00022-X","article-title":"Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease","volume":"5","author":"Knott","year":"1999","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2009.11.034","article-title":"GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein","volume":"469","author":"Koob","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.06.010_bb0205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","article-title":"Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread","volume":"69","author":"Kovacs","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0210","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/mds.22207","article-title":"Nigral burden of alpha-synuclein correlates with striatal dopamine deficit","volume":"23","author":"Kovacs","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1096\/fj.12-208660","article-title":"Attenuating astrocyte activation accelerates plaque pathogenesis in APP\/PS1 mice","volume":"27","author":"Kraft","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.06.010_bb0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JPD-2011-11004","article-title":"Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease","volume":"1","author":"Kurowska","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0225","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1093\/hmg\/dds143","article-title":"alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease","volume":"21","author":"Lastres-Becker","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.06.010_bb0230","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/ejn.12166","article-title":"Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt\/beta-catenin signaling cascade as the common final pathway for neuroprotection and self-repair","volume":"37","author":"Marchetti","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0235","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0240","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2013.07.004","article-title":"Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice","volume":"59","author":"Marxreiter","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0245","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.conb.2012.03.009","article-title":"Astrocytes conspire with neurons during progression of neurological disease","volume":"22","author":"McGann","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0250","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.06.010_bb0255","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.06.010_bb0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2011.00077","article-title":"History of innate immunity in neurodegenerative disorders","volume":"2","author":"McGeer","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0265","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1096\/fj.08-127696","article-title":"Intermediate filament transcription in astrocytes is repressed by proteasome inhibition","volume":"23","author":"Middeldorp","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.06.010_bb0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0306-4522(99)00455-8","article-title":"The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease","volume":"95","author":"Mirza","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.06.010_bb0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2002.7929","article-title":"Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment","volume":"176","author":"Mori","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2008.09.013","article-title":"DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone","volume":"33","author":"Mullett","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0290","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s11064-011-0471-9","article-title":"Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains","volume":"36","author":"Mythri","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2015.06.010_bb0295","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.010_bb0300","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0305","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/00001756-199908020-00009","article-title":"Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease","volume":"10","author":"Renkawek","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2015.06.010_bb0310","series-title":"An atlas of the basal ganglia, brain stem and spinal cord","author":"Riley","year":"1943"},{"key":"10.1016\/j.nbd.2015.06.010_bb0315","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/aws250","article-title":"S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway","volume":"135","author":"Sathe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.010_bb0320","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/hmg\/ddq564","article-title":"Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria","volume":"20","author":"Schmidt","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.06.010_bb0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(93)90796-P","article-title":"Cell and tissue distribution and developmental change of neuron specific 14kDa protein (phosphoneuroprotein 14)","volume":"622","author":"Shibayama-Imazu","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.06.010_bb0330","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0335","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1523\/JNEUROSCI.4609-07.2008","article-title":"Glial dysfunction in parkin null mice: effects of aging","volume":"28","author":"Solano","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.06.010_bb0340","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","article-title":"Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression","volume":"68","author":"Song","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0345","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.06.010_bb0350","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0355","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jnr.1171","article-title":"Glial cell death induced by overexpression of alpha-synuclein","volume":"65","author":"Stefanova","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2015.06.010_bb0360","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.010_bb0365","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00401-002-0569-x","article-title":"Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process","volume":"104","author":"Togo","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0370","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/jcbfm.2011.63","article-title":"Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies","volume":"31","author":"Tong","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2015.06.010_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2014.03.015","article-title":"Is brain gliosis a characteristic of chronic methamphetamine use in the human?","volume":"67","author":"Tong","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0380","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nbd.2010.10.017","article-title":"Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain","volume":"41","author":"Tong","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.06.010_bb0385","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awp282","article-title":"Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation","volume":"133","author":"Tong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.010_bb0390","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein","volume":"44","author":"Tu","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0395","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fnl.12.90","article-title":"Astroglia in neurological diseases","volume":"8","author":"Verkhratsky","year":"2013","journal-title":"Future Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0400","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/1073858413510208","article-title":"Astrogliopathology: A central element of neuropsychiatric diseases?","volume":"20","author":"Verkhratsky","year":"2014","journal-title":"Neuroscientist."},{"key":"10.1016\/j.nbd.2015.06.010_bb0405","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson's disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0410","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","article-title":"NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains","volume":"99","author":"Wakabayashi","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.06.010_bb0415","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(97)00891-4","article-title":"NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease","volume":"239","author":"Wakabayashi","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.06.010_bb0420","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.06.010_bb0425","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-004-0935-y","article-title":"The role of alpha-synuclein in the pathogenesis of multiple system atrophy","volume":"109","author":"Wenning","year":"2005","journal-title":"Acta Neuropathol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T20:32:56Z","timestamp":1599165176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":85,"alternative-id":["S0969996115002284"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.06.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low levels of astroglial markers in Parkinson\u2019s disease: relationship to \u03b1-synuclein accumulation","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}